Moxifloxacin Sanoswiss

Moxifloxacin, the active ingredient in Moxifloxacin Sanoswiss, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats bacterial infections such as community‑acquired pneumonia, acute sinusitis and exacerbations of chronic bronchitis in adult patients.

GNH USA supplies Moxifloxacin Sanoswiss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a fluoroquinolone antibacterial indicated for several respiratory infections. - Community‑acquired bacterial pneumonia: effective treatment of infection caused by susceptible organisms. - Acute bacterial sinusitis: reduces symptoms and bacterial load in sinus inflammation. - Acute exacerbation of chronic bronchitis: helps resolve bacterial flare‑ups in chronic bronchitis patients.

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools that may be watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or rupture, especially Achilles. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema. - Clostridioides difficile infection: severe colitis. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

Before prescribing Moxifloxacin, clinicians should consider several safety aspects. - Assess renal function: adjust therapy if renal impairment is present. - Review cardiac history: monitor QT interval in patients with cardiac disease. - Avoid use in patients with known hypersensitivity to fluoroquinolones. - Use with caution in pregnancy or breastfeeding: limited safety data. - Evaluate concomitant medications: potential for drug‑drug interactions. - Store at ambient temperature: keep in the original pack, protect from moisture.

Moxifloxacin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce oral absorption of moxifloxacin. - Warfarin: may increase anticoagulant effect and bleeding risk. - Other QT‑prolonging agents: heightened risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase central nervous system side effects. - Corticosteroids: elevated risk of tendon rupture. - Theophylline: possible increase in plasma theophylline concentrations.